Journey, John Buie TB Vaccine Accelerator Council in the works by WHO for 2023 Speaking at the World Economic Forum on January 17, 2023, Dr. Tedros Ghebreyesus, Director General of the World Health Organization (WHO), announced plans to establish a new Tuberculosis (TB) Vaccine ... Feb 12, 2023 News
Journey, John Buie Cell-derived Nanovesicles offer a promising feat in Biomedical Applications Scientists from the National University of Singapore (NUS) discovered a way to produce nano-sized vesicles from cells using a cell shearing approach called Cell-derived Nanovesicles (CDN). The finding... Feb 5, 2023 News
Journey, John Buie Cytovale receives FDA clearance for Intellisep, an early sepsis detection test US Food and Drug Administration (FDA) 510 (K) rendered clearance of Intellisep on the 5th of January this year, as part of its December 2022 decisions. Intellisep is Cytovale’s groundbreaking diagnost... Jan 29, 2023 News
Journey, John Buie FDA approved Leqembi for Alzheimer’s Disease Treatment via an Accelerated pathway The US Food and Drug Administration Center for Drug Evaluation and Research (CDER-FDA) approved Leqembi via the accelerated approval pathway to treat early and mild stages of Alzheimer’s disease. Alzh... Jan 24, 2023 News
